Read more about the article Biogen Beats Expectations, Hikes Outlook as Alzheimer’s drug Leqembi and other new Products Gain Traction
Citation: Image used for information purpose only. Picture Credit: https://www.reuters.com/

Biogen Beats Expectations, Hikes Outlook as Alzheimer’s drug Leqembi and other new Products Gain Traction

Biogen reported strong second-quarter earnings and revenue on Thursday, surpassing market expectations and prompting the company to raise its full-year guidance. The biotech firm's cost-cutting measures have begun to show…

Continue ReadingBiogen Beats Expectations, Hikes Outlook as Alzheimer’s drug Leqembi and other new Products Gain Traction